Literature DB >> 10432387

Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.

P K Datta1, E A Lianos.   

Abstract

BACKGROUND: Nitric oxide (NO) release as a result of cytokine-mediated activation of inducible nitric oxide synthase (iNOS) in mesangial cells can be sustained and lead to oxidative injury in various forms of glomerular inflammation. Inhibition of iNOS expression and/or activity could therefore be an effective anti-inflammatory strategy. The present study was undertaken to explore whether retinoids, which are known to have anti-inflammatory and immuno-modulatory actions, can attenuate cytokine-stimulated iNOS expression and enzyme activity in murine mesangial cells.
METHODS: Expression of iNOS was evaluated by NO production (nitrite analysis), protein (Western blot analysis) and mRNA (RT-PCR analysis) levels in mesangial cells stimulated by a combination of lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) in the presence and absence of all-trans-retinoic acid (ATRA) or its active metabolite, 13-cis-retinoic acid (13-cis-RA). Changes in iNOS enzyme activity were assessed by calculating conversion of L-[14C]arginine to L-[14C]citrulline. The levels of transcription factors nuclear factor-kappaB (NF-kappaB) and activated protein-1 (AP-1) in nuclear extracts prepared from mesangial cells stimulated by a combination of LPS and IFN-gamma in the presence and absence of ATRA was assessed by immunoblot analysis. The effect of both retinoids on transforming growth factor-beta1 (TGF-beta1) levels was also assessed by a quantitative enzyme immunoassay method.
RESULTS: The combination of LPS/IFN-gamma stimulated NO production, induced iNOS expression (mRNA and protein) and increased iNOS enzyme activity. ATRA and 13-cis-RA dose-dependently attenuated NO production. This effect was most pronounced at ATRA concentration of 10 microM. At this concentration, ATRA attenuated iNOS expression (mRNA and protein levels) and enzyme activity. ATRA also reduced nuclear levels of both subunits (p50 and p65) of NF-kappaB. TGF-beta1 levels in mesangial cells stimulated with LPS/IFN-gamma in presence of ATRA or 13-cis-RA were also reduced indicating that TGF-beta1 did not mediate the suppressive effect of retinoids on iNOS.
CONCLUSIONS: Our studies demonstrate that the retinoids ATRA and 13-cis-RA attenuate iNOS expression and activity in cytokine-stimulated murine mesangial cells. These retinoids may emerge as naturally occurring compounds for treatment of inflammatory glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432387     DOI: 10.1046/j.1523-1755.1999.00576.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Retinoic acid may increase the risk of bone marrow transplant nephropathy.

Authors:  Leigh Haysom; David S Ziegler; Richard J Cohn; Andrew R Rosenberg; Susan L Carroll; Gad Kainer
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

2.  Phosphatase and tensin homologue deleted on chromosome ten (PTEN) as a molecular target in lung epithelial wound repair.

Authors:  J-P Lai; J T Dalton; D L Knoell
Journal:  Br J Pharmacol       Date:  2007-10-08       Impact factor: 8.739

3.  Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice.

Authors:  Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2012-02-24       Impact factor: 4.407

4.  Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells.

Authors:  Qiuyan Chen; Yifan Ma; A Catharine Ross
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathway.

Authors:  Irina T Nizamutdinova; Rakeshwar S Guleria; Amar B Singh; Jonathan A Kendall; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

6.  The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.

Authors:  Y Nozaki; T Yamagata; B-S Yoo; M Sugiyama; S Ikoma; K Kinoshita; M Funauchi; A Kanamaru
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

7.  Effect of all-trans retinoic acid on airway inflammation in asthmatic rats and its mechanism.

Authors:  Hong Fang; Hongfang Jin; Hongwei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

8.  Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats.

Authors:  Christian Morath; Kerstin Ratzlaff; Claudius Dechow; Vedat Schwenger; Matthias Schaier; Benjamin Zeier; Jörg Peters; Miki Tsukada; Christos C Zouboulis; Rüdiger Waldherr; Marie-Luise Gross; Eberhard Ritz; Martin Zeier; Jürgen Wagner
Journal:  J Mol Med (Berl)       Date:  2008-09-16       Impact factor: 4.599

9.  The yin and yang of retinoic acid signaling in kidney diseases.

Authors:  Qingqing Wei; Zheng Dong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

10.  Retinoids as a potential treatment for experimental puromycin-induced nephrosis.

Authors:  V Moreno-Manzano; F Mampaso; J C Sepúlveda-Muñoz; M Alique; S Chen; F N Ziyadeh; M C Iglesias-de la Cruz; J Rodríguez; E Nieto; J M Orellana; P Reyes; I Arribas; Q Xu; M Kitamura; F J Lucio Cazana
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.